C. Richard (Rick) Allen, R.Ph.
Appointed as the 16th GDNA Director on April 1, 2010.
He is a graduate of the University Of Georgia College Of Pharmacy and a licensed pharmacist in Georgia. Several states have presented him with honorary pharmacist licenses.
Prior to being appointed GDNA Director, he served as the agency’s Deputy Director beginning in 1992. Before being the deputy director he worked as a GDNA Special Agent beginning his career in 1976. Prior to his joining the agency, he worked as a pharmacist for the Veteran’s Administration, the Medical College of Georgia, and in different retail pharmacy settings.
During his years with GDNA, he has worked throughout the State of Georgia investigating violations of drug and pharmacy laws and rules. He has also provided assistance to local, state and federal law enforcement and regulatory agencies throughout this country and overseas.
As part of his duties, he works closely with the Georgia State Board of Pharmacy on regulatory and enforcement matters. Each year during the Georgia Legislative Session, he is responsible for monitoring all drug and pharmacy legislation and for providing assistance and information to legislators on these types of bills.
Durig the 1980s he was assigned to the U.S. Department of Justice and the Federal Bureau of Investigation’s undercover investigation of diverted and black market pharmaceuticals, code named ‘Operation Pharmoney’. The findings of this investigation resulted in his being asked to testify before Congress on numerous occasions – testimony that helped provide the information necessary to pass the Prescription Drug Monitoring Act of 1987 (PDMA).
In 1996 he worked as a Supervisor with the Dignitary Protection Group for the Atlanta Olympic Games and served as the personal security agent for Princes Cristina of Spain during her time in Atlanta for the Olympics.
In 1997, he was elected as the President of the International Narcotic Enforcement Officers Association (INEOA), after having served the association’s vice president as well as on its Board of Directors beginning in 1987.
He has been presented with the ONDCP's National Methamphetime and Pharmaceutical Initiative Director's Award, the National Association of Boards of Pharmacy Distinguished Service Award, the Mercer University Southern College of Pharmacy Carlton Henderson Distinguished Service in Pharmacy Award, the INEOA Distinguished Service Award, and the University Of Georgia College Of Pharmacy Distinguished Alumnus Award.
He has served on the Georgia Medical Cannabis Commission in 2015 and on the Georgia State Senate's Opioid Abuse Study Committee in 2016. Currently he serves on the ONDCP High Intensity Drug Trafficking Area's (HIDTA) National Emerging Threat Initiative and as the Director of the Georgia Prescription Drug Monitoring Program (GAPDMP).